AI and blood tests join forces to catch lung cancer sooner

NCT ID NCT05368298

Ongoing Diagnosis Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects blood samples from 872 people with lung nodules to develop artificial intelligence (AI) tools that can help diagnose lung cancer earlier and more accurately. The goal is to combine blood tests with CT scans to improve detection and reduce the need for invasive procedures. Participants are adults with suspicious lung nodules found during screening who need further testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Lung Health Check Centre: Cheshire & Merseyside

Liverpool, United Kingdom
Lung Health Check Centre: Corby & Kettering

Kettering, United Kingdom
Lung Health Check Centre: Gateshead

Gateshead, United Kingdom
Lung Health Check Centre: Newcastle & Gateshead

Newcastle, United Kingdom
Lung Health Check Centre: North Bristol

Bristol, United Kingdom
Lung Health Check Centre: Plymouth

Plymouth, United Kingdom
Lung Health Check Centre: RM Partners

London, United Kingdom
Lung Health Check Centre: Royal Sussex

Brighton, United Kingdom
Lung Health Check Centre: South Tyneside and Sunderland

Sunderland, United Kingdom
Lung Health Check Centre: Stoke

Stoke, United Kingdom
Lung Health Check: Oxford - Churchill Hospital, OUH

Oxford, Oxfordshire, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.